Clinical trials

2

Search and review clinical trials. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Recruiting

Positron Emission Tomography Using 64Cu-SAR-bisPSMA in Participants With High-risk Prostate Cancer Prior to Radical Prostatectomy

The aim for this study is to assess the diagnostic performance of 64Cu-SAR-bisPSMA PET to detect regional nodal metastases.

Participants needed: 383
Trial details
Phase: Phase 3Age: 18+Biological sex: MaleType: InterventionalSponsor: Clarity Pharmaceuticals LtdUpdated: May 14, 2026Locations: 31
Eligibility criteria

At least 18 years of age. [+4]

Administration of any high energy (>300 KeV) gamma-emitting radioisotope within... [+2]

Status: Recruiting

64Cu-SAR-bisPSMA and 67Cu-SAR-bisPSMA for Identification and Treatment of PSMA-expressing Metastatic Castrate Resistant Prostate Cancer (SECuRE)

The aim of this study is to determine the safety and efficacy of 67Cu-SAR-bisPSMA in participants with PSMA-expressing metastatic castrate resistant prostate cancer.

Participants needed: 54
Trial details
Phase: Phase 1, Phase 2Age: 18+Biological sex: MaleType: InterventionalSponsor: Clarity Pharmaceuticals LtdUpdated: May 6, 2026Locations: 7
Eligibility criteria

Signed informed consent; [+23]

Major surgery within 12 weeks prior to enrollment into the study; [+23]